310 related articles for article (PubMed ID: 22046307)
1. Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice.
Westmark CJ; Westmark PR; O'Riordan KJ; Ray BC; Hervey CM; Salamat MS; Abozeid SH; Stein KM; Stodola LA; Tranfaglia M; Burger C; Berry-Kravis EM; Malter JS
PLoS One; 2011; 6(10):e26549. PubMed ID: 22046307
[TBL] [Abstract][Full Text] [Related]
2. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
3. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
[TBL] [Abstract][Full Text] [Related]
4. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.
Sokol DK; Maloney B; Long JM; Ray B; Lahiri DK
Neurology; 2011 Apr; 76(15):1344-52. PubMed ID: 21482951
[TBL] [Abstract][Full Text] [Related]
5. The small GTPase Arf6 is dysregulated in a mouse model for fragile X syndrome.
Briševac D; Scholz R; Du D; Elagabani MN; Köhr G; Kornau HC
J Neurochem; 2021 May; 157(3):666-683. PubMed ID: 33125726
[TBL] [Abstract][Full Text] [Related]
6. MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta.
Westmark CJ; Westmark PR; Malter JS
Int J Clin Exp Pathol; 2009 Oct; 3(1):56-68. PubMed ID: 19918329
[TBL] [Abstract][Full Text] [Related]
7. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
9. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
[TBL] [Abstract][Full Text] [Related]
10. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
11. Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.
Costa L; Spatuzza M; D'Antoni S; Bonaccorso CM; Trovato C; Musumeci SA; Leopoldo M; Lacivita E; Catania MV; Ciranna L
Biol Psychiatry; 2012 Dec; 72(11):924-33. PubMed ID: 22817866
[TBL] [Abstract][Full Text] [Related]
12. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.
Toft AK; Lundbye CJ; Banke TG
J Neurosci; 2016 Sep; 36(38):9817-27. PubMed ID: 27656021
[TBL] [Abstract][Full Text] [Related]
14. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.
Goebel-Goody SM; Wilson-Wallis ED; Royston S; Tagliatela SM; Naegele JR; Lombroso PJ
Genes Brain Behav; 2012 Jul; 11(5):586-600. PubMed ID: 22405502
[TBL] [Abstract][Full Text] [Related]
15. Audiogenic Seizures in the
Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
Nosyreva ED; Huber KM
J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
[TBL] [Abstract][Full Text] [Related]
17. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
[TBL] [Abstract][Full Text] [Related]
18. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
Niere F; Wilkerson JR; Huber KM
J Neurosci; 2012 Apr; 32(17):5924-36. PubMed ID: 22539853
[TBL] [Abstract][Full Text] [Related]
20. Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse.
Higashimori H; Morel L; Huth J; Lindemann L; Dulla C; Taylor A; Freeman M; Yang Y
Hum Mol Genet; 2013 May; 22(10):2041-54. PubMed ID: 23396537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
